Search for: "Hoffman v. Hoffman" Results 1121 - 1140 of 1,632
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against APP Pharmaceuticals following Para IV challenge… [read post]
22 Mar 2011, 4:21 pm by Marie Louise
Brownback’s 2010 version (FDA Law Blog) US: Effective March 28, 2011 – New safety reporting requirements for certain drug and biological products (FDA Law Blog) US: FDA issues new guidance on PDUFA user fee waivers, reductions, and refunds; guidance represents the culmination of 18 years of FDA experience (FDA Law Blog) US: Affymetrix files for correction of inventorship: Affymetrix v Illumina (Patent Docs) US: Hoffman-La Roche files for review and correction of patent… [read post]
13 Sep 2011, 5:13 am
Although courts have ruled that members of a union may be “third party beneficiaries” of a contract between the employer and the union [Helt v Britten-Fenton Co., 180 Misc 1077], the Court of Appeals has declared that the benefit “must be one that is not merely incidental, but must be immediate in such a sense and degree as to indicate the assumption of a duty to make reparation if the benefit is lost” [Associated Flour Haulers and Warehousemen v… [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in… [read post]
26 Jan 2010, 6:16 pm by ALeonard
This was apparently influenced as well by a recent New York State Appellate Division ruling in Hoffman v. [read post]